Tag: VIVE

Blue Horseshoe Stocks: More Big Moves From ROKU

TBSS International, Inc. TBSS

Our first order of business as we open up the books on another fresh trading week, is to update readers on the performance of TBSS, an OTC stock that we tagged for observation in Thursday morning’s extended watchlist.

It showed why, despite primarily focusing on the big boards and options plays these days, we are still perfectly willing to take it back to our roots and ID high potential plays on the lower exchanges.

The stock traded from a low of .0111 on Thursday morning, and reached a new high of .0219 Friday. That represents an overnight swing of 97%

Roku, Inc. ROKU 

Next up, we want to highlight the advances made by our ROKU options ideas. As we were mentioning on Friday, on the morning of September 23rd we tagged the ROKU 11/01 $115-118 Calls for extended observation. We were just going over the total possible gains on Friday morning, but after another solid session, those figures require updating once again.

$115 Calls – Range: 3.00-12.75 – Max Gain: 325%
$116 Calls – Range: 3.60-12.00 – Max Gain: 233%
$117 Calls – Range: 2.82-11.30 – Max Gain: 301%
$118 Calls – Range: 2.50-10.75 – Max Gain: 330%

Additionally, we included two rolled up strike prices to watch in the ROKU chain, the Weekly $122-123 Calls, and those were an instant success. The $122 Calls ran 219% intraday from 72-2.30, while the $123’s pushed from a low of .48 and hit 1.70, a gain of 254%

Fresh Idea:
JELD-WEN Holding Inc JELD 12/20 $15-17.50 Calls

Extended Watchlist:
VIVE, CTXR, GSV, LODE, TEUM, FCEL, SES, AWSM, IGC

Blue Horseshoe Stocks: Bearish Options, Bottom Play

Cracker Barrel Old Country Store Inc. CBRL – Recap

First up this morning is a quick recap of the fresh options idea we formulated for yesterday morning’s premarket report. We had designated the CBRL Weekly $165-170 Calls as our targets of interest.

Two of those three contract sets produced opportunities for multi-bag gains on the day, with the third not far behind: 

$165 Calls – Range: 5.25-9.57 – Max Gain: 227%
$167.50 Calls – Range: 1.20-3.50 – Max Gain: 393%
$170 Calls – Range: .56-1.45 – Max Gain: 227%

DURRECT Corp. DRRX – Recap 

DRRX is a play that we began tracking last month (08/07). Following that initial report, we observed the stock trading for as little 1.22.

In the four weeks which have followed, DRRX has been a steady riser, stair-stepping its way gradually up to its new high yesterday of an even 2.00/share. That works out to a very respectable rise of 64%

Neurotrope, Inc. NTRP

We also want to shine a light on the current setup of the chart on NTRP. Poor marks on for its Alzheimer’s treatment should have pushed it down quite a bit, but there seems to be no readily apparent reason why the stock should have fallen as low as it did following the lackluster report on the company’s clinical trials.

At present the stock is hugely oversold, and from a technical standpoint alone, could begin a reversal on little more than a breath of air. Indication from the MACD suggests convergence toward a bullish cross in the making. Should enough people catch on to the present scenario and load up cheap shares at current pricing, it could happen sooner rather than later. Even a partial fill of the massive gap on the chart would mean big gain chances.

Fresh Options Ideas:
FDX Weekly $157.50-155 Puts
UPS Weekly $120-119 Puts 

Extended Watchlist:
SINT, VIVE, GHSI, OPGN, JAGX, ROAD, TTNP, BE

Blue Horseshoe Stocks: SRPT Bottom-Watch

Ulta Beauty, Inc. ULTA

Before we broke for the holiday weekend on Friday, we designated a last minute bearish options idea for ULTA in our premarket report, and thanks to a lackluster day for stocks in general as the markets fell, we saw some nice gains out of those plays, which were the ULTA Weekly $265-260 Puts..

The company also had reported and missed on earnings, receiving multiple analyst downgrades to add fuel to the fire. All of those elements converged to make for the following possible gains for anyone who had caught our alert in the morning.

The $265 Puts traded up from a low of 12.30 and more than doubled as they ran to 26.46 for an intraday move of 115%  The $260’s posted an even bigger gain, running form 7.40-19.90, which worked out to a total possible profit of 169%

Sarepta Therapeutics, Inc. SRPT 

We want to take a look at SRPT as we kick off this short trading week, and form an extended term idea. The stock is heavily oversold at present time as it searches out a bottom, and we would like to be ready and waiting when what we feel is an imminent recovery begins.

There is also a massive topside gap on the SRPT chart that could give the stock even more breathing room when it finally makes its reversal and begins to trend up again. We are going to give ourselves plenty of time on this one, signaling the SRPT 10/04 $91.50-94 Calls to watch in coming weeks.

Extended Watchlist:
VIVE, ARDX, GGAL, TBLT, BNGO, SUPV, TBLT, PGSY